Chen et al. discovered that NCAPH has the ability to upregulate the expression of PD-L1 by impeding the degradation of β-catenin protein in clear cell renal cancer cells, causing the enhancement of aerobic glycolysis and immune tolerance in these cells. The gene discussed is NCAPH; the disease is clear cell renal carcinoma.